Abstract

Prenatal genetic screening and diagnostic testing should be offered in every pregnancy as a standard of care in the United States. This testing is important for patients who choose to continue their pregnancies, but it is also common for patients to choose termination after a positive result. Options for diagnostic testing vary by gestational age, with chorionic villus sampling (CVS) offered at an earlier gestational age (10-13 weeks) than amniocentesis (15 weeks gestation). Our objective was to determine the effect of new gestational age-based abortion restrictions on options for feasible genetic diagnostic testing by state.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.